This clinical trial is testing an investigational mRNA-based acne vaccine for adults aged 18-45 with moderate to severe acne. The study aims to evaluate the vaccine's safety and effectiveness by targeting C. acnes bacteria, which contribute to inflammation and acne development. Participants would need to complete 13 in-person visits to our clinic over approximately 8 months, selected participants will be given the option to be followed up for 3 years.
Apply Now
This study is testing a new investigational injection to see if it can safely improve symptoms in adults with moderate to severe atopic dermatitis. This study is taking place at our Brisbane, Canberra, Central Coast and Western Sydney Clinics.
Apply Now
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
